RxDoctor Payments Data

Tracie Cox, CNM

Advanced Practice Midwife · Baltimore, MDNPI 1639516263

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Exeltis, USA Inc. at 29.4% of the total. 2025 is the largest year on record at $302, 3.6 times the $84 reported in 2021. Among advanced practice midwife clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,103in general payments, 2019–2025

Across 53 payments — averaging $20.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exeltis, USA Inc.$324
  • Scynexis, Inc.$196
  • Astellas Pharma US Inc$121
  • Mayne Pharma Commercial LLC$119
  • Sage Therapeutics, LLC$54
  • Hologic Sales And Service, LLC$49
  • plus $240 from 11 others

What the payments were for

  • Food & beverage$1,103100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,103 in reported general payments places this provider in the 90th percentile of 164 advanced practice midwife providers in Maryland.

See all advanced practice midwife providers in Maryland

Medicare billing

Part B allowed, 2024
$1,787
Medicare patients
24
Services billed
29

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip11$332

Paid to pharmacies, not to this prescriber.

Other advanced practice midwife in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →